The panel will reportedly be chaired by Health and Human Services Secretary Robert F. Kennedy Jr. and Kathryn Burgum.

Access to biologic therapy, such as omalizumab, is a significant barrier for CSU patients in Latin America, despite high disease knowledge. Participants in the pilot program had high baseline ...

President Trump signed an executive order aimed at combating drug addiction and substance abuse on Thursday, dubbing it “the ...

A Yolo County Superior Court judge continued a felony probation violation matter following an Admit or Deny Violation of Probation hearing, which focused on the availability of mental health diversion ...

Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute In SUPPORT of Senate Bill 421, “Pharmacist; remote verification and counseling in opioid treatment programs.” ...

Acne vulgaris is a chronic inflammatory skin disorder driven by bacterial overgrowth and persistent inflammation, often requiring combination therapy ...

Kitsap County officials announced a total allotment for opioid settlement funding after spending about $800k over the past ...

Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...

In Bayer’s new “Life Doesn’t Stop for a Hot Flash” campaign, Gabrielle Union-Wade discusses her personal experiences with ...

The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...

Readers respond to a guest essay about the methods and reliability of science. Also: Opioid addiction; judges and presidents; ...

ASK THE PEDIATRICIAN: The U.S. Food and Drug Administration is concerned about kratom and continues to investigate its health ...